Brugada syndrome genetic testing: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Brugada syndrome}} | {{Brugada syndrome}} | ||
{{CMG}} | {{CMG}} | ||
| Line 8: | Line 9: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs content]] | |||
[[Category:Electrophysiology]] | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category: | [[Category:Channelopathy]] | ||
[[Category:Genetic disorders]] | |||
{{WH}} | |||
{{WS}} | |||
Revision as of 21:01, 10 January 2013
|
Brugada syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Brugada syndrome genetic testing On the Web |
|
American Roentgen Ray Society Images of Brugada syndrome genetic testing |
|
Risk calculators and risk factors for Brugada syndrome genetic testing |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Despite the association of the Brugada syndrome with the SCN5A genotype, there is unfortunately no association between the results of genetic testing and clinical prognosis. Genetic testing can be used to support the diagnosis of Brugada syndrome and to detect relatives at risk.[1]
References
- ↑ Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A (2005). "Brugada syndrome: report of the second consensus conference". Heart Rhythm : the Official Journal of the Heart Rhythm Society. 2 (4): 429–40. PMID 15898165. Unknown parameter
|month=ignored (help);|access-date=requires|url=(help)